Clinical course and outcome of patients with high-level microsatellite instability cancers in a real-life setting: a retrospective analysis
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The prognostic and predictive significance of the high-level microsatellite instability (MSI-H) phenotype in various malignancies is unclear. We describe the characteristics, clinical course, and outcomes of patients with MSI-H malignancies treated in a real-life hospital setting. PATIENTS AND METHODS: A retrospective analysis of MSI-H cancer patient files was conducted. We analyzed the genetic data, clinical characteristics, and oncological treatments, including chemotherapy and surgical interventions. RESULTS: Clinical data of 73 MSI-H cancer patients were available. Mean age at diagnosis of first malignancy was 52.3 years. Eight patients (11%) had more than four malignancies each. Most patients (76%) had colorectal cancer (CRC). Seventeen patients (23%) had only extracolonic malignancies. Eighteen women (36%) had gynecological malignancy. Nine women (18%) had breast cancer. Mean follow-up was 8.5 years. Five-year overall survival and disease-free survival of all MSI-H cancer patients from first malignancy were 86% and 74.6%, respectively. Five-year overall survival rates of stage 2, 3, and 4 MSI-H CRC patients were 89.5%, 58.4%, and 22.9%, respectively. CONCLUSION: Although the overall prognosis of MSI-H cancer patients is favorable, this advantage may not be maintained in advanced MSI-H CRC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“including Buolamwini and Gebru's (2018) audit study, which demonstrated that AI systems used to classify images of people according to gender were significantly more accurate when applied to lighter-skinned males than darker-skinned females.”
From Auditing of AI: Legal, Ethical and Technical Approaches (2023) · cites this paper as Buolamwini and Gebru's (2018)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130
VASEN, H., WATSON, P., MECKLIN, J., & LYNCH, H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70510-x · Cited by 2,519
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Sargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623
Saam, J., Arnell, C., Theisen, A., Moyes, K., Marino, I., Roundy, K. M., & Wenstrup, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,526
Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal Cancer
Gryfe, R., Kim, H., Hsieh, E. T. K., Aronson, M. D., Holowaty, E. J., Bull, S. B., Redston, M., & Gallinger, S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420201 · Cited by 1,388
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham, J. M., Christensen, E. R., Tester, D. J., Kim, C. Y., Roche, P. C., Burgart, L. J., & Thibodeau, S. N. (1998) · PubMed · Cited by 1,005
Burn, J., Gerdes, A.-M., Macrae, F., Mecklin, J.-P., Moeslein, G., Olschwang, S., Eccles, D., Evans, D. G., Maher, E. R., Bertario, L., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61049-0 · Cited by 952
Milestones of Lynch syndrome: 1895–2015
Lynch, H. T., Snyder, C. L., Shaw, T. G., Heinen, C. D., & Hitchins, M. P. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3878 · Cited by 810
Venderbosch, S., Nagtegaal, I. D., Maughan, T. S., Smith, C. G., Cheadle, J. P., Fisher, D., Kaplan, R., Quirke, P., Seymour, M. T., Richman, S. D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0332 · Cited by 772
Hutchins, G., Southward, K., Handley, K., Magill, L., Beaumont, C., Stahlschmidt, J., Richman, S., Chambers, P., Seymour, M., Kerr, D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1366 · Cited by 681
The surveillance, epidemiology, and end results program: a national resource.
Hankey, B. F., Ries, L. A. G., & Edwards, B. K. (1999) · PubMed · Cited by 594
PD-1 blockade in tumors with mismatch repair deficiency.
Le, D. T., Uram, J. N., Wang, H., Bartlett, B., Kemberling, H., Eyring, A., Skora, A., Azad, N. S., Laheru, D. A., Donehower, R. C., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.33.15_suppl.lba100 · Cited by 565
Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival
Phipps, A. I., Limburg, P. J., Baron, J. A., Burnett-Hartman, A. N., Weisenberger, D. J., Laird, P. W., Sinicrope, F. A., Rosty, C., Buchanan, D. D., Potter, J. D., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.038 · Cited by 401
Bertagnolli, M. M., Niedzwiecki, D., Compton, C. C., Hahn, H. P., Hall, M., Damas, B., Jewell, S. D., Mayer, R. J., Goldberg, R. M., Saltz, L. B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2071 · Cited by 364
Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes
Sinicrope, F. A., Shi, Q., Smyrk, T. C., Thibodeau, S. N., Dienstmann, R., Guinney, J., Bot, B. M., Tejpar, S., Delorenzi, M., Goldberg, R. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.041 · Cited by 330
Des Guetz, G., Schischmanoff, O., Nicolas, P., Perret, G.-Y., Morere, J.-F., & Uzzan, B. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.018 · Cited by 291
Goldstein, J., Tran, B., Ensor, J., Gibbs, P., Wong, H. L., Wong, S. F., Vilar, E., Tie, J., Broaddus, R., Kopetz, S., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu100 · Cited by 288
Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer
Roth, A. D., Delorenzi, M., Tejpar, S., Yan, P., Klingbiel, D., Fiocca, R., d'Ario, G., Cisar, L., Labianca, R., Cunningham, D., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs427 · Cited by 284
Sinicrope, F. A., Mahoney, M. R., Smyrk, T. C., Thibodeau, S. N., Warren, R. S., Bertagnolli, M. M., Nelson, G. D., Goldberg, R. M., Sargent, D. J., & Alberts, S. R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.48.9591 · Cited by 279
Reduced Likelihood of Metastases in Patients with Microsatellite-Unstable Colorectal Cancer
Malesci, A., Laghi, L., Bianchi, P., Delconte, G., Randolph, A., Torri, V., Carnaghi, C., Doci, R., Rosati, R., Montorsi, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0366 · Cited by 245
Klingbiel, D., Saridaki, Z., Roth, A. D., Bosman, F. T., Delorenzi, M., & Tejpar, S. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu499 · Cited by 231
Miyakura, Y., Sugano, K., Konishi, F., Ichikawa, A., Maekawa, M., Shitoh, K., Igarashi, S., Kotake, K., Koyama, Y., & Nagai, H. (2001) · Gastroenterology · doi:10.1053/gast.2001.29616 · Cited by 203
Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer
Seppälä, T. T., Böhm, J. P., Friman, M., Lahtinen, L., Väyrynen, V. M. J., Liipo, T. K. E., Ristimäki, A. P., Kairaluoma, M. V. J., Kellokumpu, I. H., Kuopio, T. H. I., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.160 · Cited by 154
Clancy, C., Burke, J. P., Kalady, M. F., & Coffey, J. C. (2013) · Colorectal Disease · doi:10.1111/codi.12427 · Cited by 133
Risk of breast cancer in Lynch syndrome: a systematic review
Win, A. K., Lindor, N. M., & Jenkins, M. A. (2013) · Breast Cancer Research · doi:10.1186/bcr3405 · Cited by 129
de Vos tot Nederveen Cappel, W. H., Meulenbeld, H. J., Kleibeuker, J. H., Nagengast, F. M., Menko, F. H., Griffioen, G., Cats, A., Morreau, H., Gelderblom, H., & Vasen, H. F. A. (2004) · International Journal of Cancer · doi:10.1002/ijc.11712 · Cited by 118
Morgan Rouprêt, A., Fromont, G., Azzouzi, A.-R., Catto, J. W., Vallancien, G., Hamdy, F. C., & Cussenot, O. (2005) · Urology · doi:10.1016/j.urology.2005.01.019 · Cited by 88
High microsatellite instability predicts good prognosis in intestinal‐type gastric cancers
Kim, H., An, J. Y., Noh, S. H., Shin, S. K., Lee, Y. C., & Kim, H. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06487.x · Cited by 79
Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy
Kim, S. T., Lee, J., Park, S. H., Park, J. O., Lim, H. Y., Kang, W. K., Kim, J. Y., Kim, Y. H., Chang, D. K., Rhee, P., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1206-3 · Cited by 78
Harkness, E. F., Barrow, E., Newton, K., Green, K., Clancy, T., Lalloo, F., Hill, J., & Evans, D. G. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103216 · Cited by 77
Fang, W., Chang, S., Lan, Y., Huang, K., Chen, J., Lo, S.-S., Hsieh, M., Li, A. F., Wu, C.-W., & Chiou, S. (2012) · World Journal of Surgery · doi:10.1007/s00268-012-1652-7 · Cited by 76
Chemosensitivity and Survival in Gastric Cancer Patients with Microsatellite Instability
Oki, E., Kakeji, Y., Zhao, Y., Yoshida, R., Ando, K., Masuda, T., Ohgaki, K., Morita, M., & Maehara, Y. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0580-8 · Cited by 74
Towards a vaccine to prevent cancer in Lynch syndrome patients
Doeberitz, M. V. K., & Kloor, M. (2013) · Familial Cancer · doi:10.1007/s10689-013-9662-7 · Cited by 63
Brueckl, W. M., Moesch, C., Brabletz, T., Koebnick, C., Riedel, C., Jung, A., Merkel, S., Schaber, S., Boxberger, F., Kirchner, T., et al. (2003) · PubMed · Cited by 60
NCCN Increases the Emphasis on Genetic/Familial High-Risk Assessment in Colorectal Cancer
Hampel, H. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0200 · Cited by 57
Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified
Ward, R. L., Turner, J., Williams, R., Pekarsky, B. A. K., Packham, D., Velickovic, M., Meagher, A. P., O'Connor, T. W., & Hawkins, N. J. (2005) · The Journal of Pathology · doi:10.1002/path.1851 · Cited by 53
Golan, T., Urban, D., Berger, R., & Lawrence, Y. R. (2013) · Cancer · doi:10.1002/cncr.28143 · Cited by 47
Ooki, A., Akagi, K., Yatsuoka, T., Asayama, M., Hara, H., Takahashi, A., Kakuta, M., Nishimura, Y., & Yamaguchi, K. (2014) · Journal of Surgical Oncology · doi:10.1002/jso.23755 · Cited by 33
Genetics, Biomarkers, Hereditary Cancer Syndrome Diagnosis, Heterogeneity and Treatment: A Review
Lynch, H. T., Drescher, K. M., Knezetic, J. A., & Lanspa, S. J. (2014) · Current Treatment Options in Oncology · doi:10.1007/s11864-014-0293-5 · Cited by 26
Is breast cancer a part of Lynch syndrome?
Ford, J. M. (2012) · Breast Cancer Research · doi:10.1186/bcr3241 · Cited by 15
Is the controversy on breast cancer as part of the Lynch-related tumor spectrum still open?
Grandval, P., Barouk-Simonet, E., Bronner, M., Buisine, M., Moretta, J., Tinat, J., & Olschwang, S. (2012) · Familial Cancer · doi:10.1007/s10689-012-9562-2 · Cited by 13
Steinbakk, A., Malpica, A. L., Slewa, A., Gudlaugsson, E. G., Janssen, E. A. M., Arends, M. J., Kruse, A., Yu, Y., Feng, W., & Baak, J. P. A. (2011) · Cellular Oncology · doi:10.1007/s13402-011-0040-x · Cited by 12
Steinbakk, A., Malpica, A. L., Slewa, A., Gudlaugsson, E. G., Janssen, E. A. M., Arends, M. J., Kruse, A., Yinhua, Y., Feng, W., & Baak, J. P. A. (2010) · Analytical Cellular Pathology · doi:10.1155/2010/430389 · Cited by 12
Oncologic Outcomes after Adjuvant Chemotherapy Using FOLFOX in MSI‐H Sporadic Stage III Colon Cancer
Oh, S. Y., Kim, D. Y., Kim, Y. B., & Suh, K. W. (2013) · World Journal of Surgery · doi:10.1007/s00268-013-2120-8 · Cited by 10
Laghi, L., Bianchi, P. P., & Malesci, A. (2003) · Gastroenterology · doi:10.1053/gast.2003.50199 · Cited by 10
Morgan Rouprêt, A., Fromont, G., Cancel‐Tassin, G., Azzouzi, A.-R., Catto, J. W. F., Hamdy, F., Vallancien, G., Richard, F., & Cussenot, O. (2006) · European Urology Supplements · doi:10.1016/s1569-9056(06)60371-0 · Cited by 2
Steinbakk, A., Malpica, A. L., Slewa, A., et al. (2010) · PubMed · doi:10.3233/acp-clo-2010-0550
Cited by
Auditing Large Language Models: A Three-Layered Approach
Mökander, J., Schuett, J., Kirk, H. R., & Floridi, L. (2023) · doi:10.2139/ssrn.4361607 · Cited by 292
Auditing large language models: a three-layered approach
Mökander, J., Schuett, J., Kirk, H. R., & Floridi, L. (2023) · arXiv · doi:10.48550/arxiv.2302.08500 · Cited by 292
Auditing large language models: a three-layered approach
Mökander, J., Schuett, J., Kirk, H. R., & Floridi, L. (2024) · AI and Ethics · doi:10.1007/s43681-023-00289-2 · Cited by 289
Auditing of AI: Legal, Ethical and Technical Approaches
Mökander, J. (2023) · Digital Society · doi:10.1007/s44206-023-00074-y · Cited by 152
AI ageism: a critical roadmap for studying age discrimination and exclusion in digitalized societies
Stypinska, J. (2023) · AI & SOCIETY · doi:10.1007/s00146-022-01553-5 · Cited by 133
Metadata
- Authors
- Halpern, N., Goldberg, Y., Kadouri, L., Duvdevani, M., Hamburger, T., Peretz, T., & Hubert, A.
- Affiliations
- Sheba Medical Center (IL)
- Hebrew University of Jerusalem (IL)
- Corresponding author
- Halpern, Naama
- Venue
- OncoTargets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2017-03
- Volume
- Volume 10
- Pages
- 1889-1896
- ISSN
- 1178-6930 (ISSN-L)
- PMC
- PMC5384685
- OpenAlex
- W2604790242
- Cited by
- 23
- References
- 51
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 7 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 1
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- OncoTargets and Therapy (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (acceptedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- colorectal cancer, overall survival, disease-free survival, prognosis, extracolonic malignancies, gynecologic cancer, breast cancer, stage at diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.